We have observed
2 EP applications
Unto Tapani Hakola
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 29, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
An extendable profile